BSEInsider Trading / SAST30 Oct 2026 · 30 Oct 2026, 10:42 am
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Venkaiah Chowdary Nannapaneni
Natco Pharma Ltd · 524816
✦ AI SummaryResults
Natco Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the allotment of equity shares through a rights issue to eligible equity shareholders. The disclosure includes details of the promoters and members of the promoter group who have acquired shares through the allotment.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
29DB7641_EC47_4884_97E7_51B39FB4AE6A_104226.pdf
View document text
N atco Pharma Limited
Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad -500034.
Telangana, INDIA. Tel: +91 40 23547532, Fax: +91 40 23548243
CIN: L24230TG1981PLC003201, www.natcopharma.co.in
29th October, 2026
Corporate Relationship Department The Manager - Listing
The BSE LTD M/s. National Stock Exchange of India Ltd
Mumbai 400 001 Bandra (E) Mumbai 400 051
Scrip Code: 524816 Scrip Code: NATCOPHARM
Dear Sir(s),
Sub:- Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers)
Regulations, 2011 & disclosure under Regulation 7(2) read with Regulation 6(2) of SEBI
(Prohibition of Insider Trading) Regulations, 2015
With reference to the above-cited subject, thP. r0n,~;:ir1,' has allotted Equity Shares through Rights
Issue to the eligible Equity Shareholders of the Company.
In this connection, please find enclosed herewith the (fo,closures under Regulation 29(2) of SEBI
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and disclosure under
Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015
from the following Promoter(s) & Member(s) of the Promoter Group pursuant to allotment of
Equity Shares:
SI. No. Name of the Promoter(s) & Member(s) of the Promoter No. of Shares acquired
Group through allotment
1 Venkaiah Chowdary Nannapaneni 5,86,666
2 Neelima Sita Nannapaneni 2,55,387
3 Rajeev Nannapaneni 58,666
4 VS Swathi Kantamani 61,333
5 KR Kumar 4,761
6 Time Cap Pharma Labs Private Limited 9,33,333
7 Natsoft Information Systems Private Limited 2,40,000
8 Vistra ITCL India Limited A/C Neelima Nannapaneni Trust 69,785
9 Vistra ITCL India Limited A/C VCN Family Trust 161
10 Natco Aqua Limited 1,523
11 SAU Family Trust 161
This is for your information and records.
Thanking you
Encl: as above.
Format for Disclosures under Regulation 29(2) of SEBI
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011
1. Name of the Target Company (TC) NATCO Pharma Limited
2. Name (s) of the acquirer and Persons acting in VENKAIAH CHOWDARY NANNAPANENI
Concert (PAC) with the acquirer
3. Whether the acquirer belongs to Promoter/ Promoter
Promoter Group
4. Name(s) of the Stock Exchange (s) where the NSE & BSE
shares of TC are Listed
5. Details of the acquisition or disposal/holding Number % w.r.t. total % w.r.t. total
of shares /voting rights/holding of the acquirer share/voting diluted
and PAC capital share/voting
wherever capital of
applicable the TC(*)
Before the acguisitionleisE!esal under
consideration, holding of:
a) Shares carrying voting rights 2,80,45,905 14.30 14.30
b) Shares in the nature of encumbrance
(pledge/ lien/ non-disposal undertaking/
others)
c) Voting rights (VR) otherwise than by
shares
d) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding in
each category)
Total (A+B+C+D) 2,80,45,905 14.30 14.30
Details of acguisitionl&ale
a) Shares carrying voting rights 5,86,666 0.30 0.30
acquired/seW
b) VRs acquired /sold otherwise than
by shares
c) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding in
each category) acquired/sold
d) Shares encumbered / invoked / released
by the acquirer
Total (A+B+C+D) 5,86,666 0.30 0.30
After the acquisition/sale, holding of:
a) Shares carrying voting rights 2,86,32,571 14.60 14.60
b) Shares encumbered with the acquirer
c) VRs otherwise than by shares
d) Warrants/convertible securities/any
other instrument that entitles the
acquirer to receive shares carrying
voting rights in the TC (specify holding
in each category) after acquisition
Total (A+B+C+D) 2,86,32,571 14.60 14.60
6. Mode of acquisition/ sale (e.g. open Rights Issue
market/ off-market/ public issue/
rights issue/ preferential allotment/
inter-se transfer etc).
7. Date of acquisition/ sale of shares/ VR 26/10/2026
or date of receipt of intimation of
allotment of shares, whichever is
applicable
8. Equity share capital/total voting
capital of the TC before the said 17,91,09,870 equity shares of Rs.2/-each
acquisition/ sale-
9. Equity share capital/ total voting capital
of the TC after the said acquisition/ sale- 19,61,67,952 equity shares of Rs.2/-each
10. Total diluted share/voting capital of the 19,61,67,952 equity shares of Rs.2/-each
TC after the said acquisition/sale-.
Note:(*) Diluted share/voting capital means the total number of shares in the TC assuming full
conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Signature of the Ac:irc eller / l\uthorized Signatory
Place: Hyderabad
Date: 28-10-2026
FORMC
SEBI (Prohibition of Insider Trading) Regulations, 2015
[Regulation 7 (2) read with Regulation 6(2) - Continual disclosure]
Name of the Company: Natco Pharma Limited
ISIN of the Company: INE987B01026
Details of change in holding of Securities of Promoter, Member of the Promoter Group, Designated Person or Director of a listed company and immediate
relatives of such persons and other such persons as mentioned in Regulation 6(2)
Name, PAN, CIN/DIN, & Category of Securities held prior to Securities acquired/disposed/pledged Securities held post Date of allotment advice/ Date of Mode of Exch
address with contact nos. Person acquisition/disposal/pledg acquisition/disposal/pledg acquisition of shares,Lsale intimation to acquisition/ ange
(Promoter/ e e of shaFesfpledge, speeify company disposal (on on
member of Type of No. and% of Type of No. Value Transaction Type of No. and %of From To market/public/ whic
the security shareholding securit Type (Purchase/ security shareholding rights/ h the
promoter (For e.g. y (For Sale/ Pledge/ (For e.g. preferential trade
group/desi -Shares, e.g.- Reva eati o At -Shares, offer I off was
gnated Warrants Shares, iA•1oeatioAt Warrants market/ Inter- exec
person/Dir Warran other please se transfer, uted
ector Converti ts, SJ}ei€fy-) Converti ESOPs etc.)
s/immediat ble Conver ble
e relative Debentur tible Debentur
to/others es, rights Debent es,
etc.) entitleme ures, rights
nts, etc.) rights entitlem
entitle ents,
ment, etc.)
etc.)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
Venkaiah Chowdary Promoter Equity 2,80,45,905 Equity 5,86,666 43,99,99,500 Buy Equity 2,86,32,571 26/10/2026 26/10/2026 28/10/2026 Rights Issue NA
Nannapaneni & & Allotment
8-2-293/82/A/530 Road No 14.30% 14.60%
26 Jubilee Hills Hyderabad-
500033, India
PAN: ABEPN6301L
Contact: 040 23547532
Details of trading in derivatives on the securities of the company by Promoter, member of the promoter group, designated person or Director of a listed company
and immediate relatives of such pE!rse>__ns~n~ ot!ier_ such persons as m_en!ion_ed_in ~eg_ul~tio_11612)
Trading in derivatives (Specify type of contract, Futures or Options etc.) Exchange on which the trade was executed
Type of Contract Contract Buy Sell
specifications Notional Value Number of units (contracts* lot size) Notional Value Number of units (contracts * lot size)
(16) (17) (18) (19) (20) (21) (22)
NA NA NA NA NA NA NA
Name: Venkaiah Chowdary Njnnapaneni
--------i;:-"~◄111a::C-::,,,Z~:-->--
Signature: Date: 28/10/2026
Designation: Promoter Place: Hyderabad
Format for Disclosures under Regulation 29(2) of SEBI
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011
1. Name of the Target Company (TC) NATCO Pharma Limited
2. Name (s) of the acquirer and Persons acting in RAJEEV NANNAPANENI
Concert (PAC) with the acquirer
3. Whether the acquirer belongs to Promoter/ Promoter
Promoter Group
4. Name(s) of the Stock Exchange (s) where the NSE & BSE
shares of TC are Listed
5. Details of the acquisition or disposal/holding Number % w.r.t. total % w.r.t. total
of shares /voting rights/holding of the acquirer share/voting diluted
and PAC capital share/voting
wherever capital of the
applicable TC(*)
Before the acguisition[elis~esal under
conside
[Showing first 8,000 characters — download PDF for full document]